Streetbeat News

Products Services

NVNO

EnVVeno Medical reported positive interim data from its SAVVE U.E. pivotal trial for the VenoValve, showing significant healing in venous ulcer patients. The company plans to seek FDA approval in Q4 2024.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2024 | 12:39 pm

ENOV

PEN

RGEN

The article highlights three oversold health care stocks with RSI values near or below 30, indicating potential buying opportunities. The stocks mentioned are Repligen Corp (RGEN), Enovis Corp (ENOV), and Penumbra Inc (PEN).

Portfolio Pulse from Avi Kapoor

June 21, 2024 | 12:22 pm

NVDA

TSLA

Tesla Inc. (NASDAQ:TSLA) plans to expand its Giga Texas facility to include a new data center with over 500MW capacity in the next 18 months. This center will house Tesla's AI hardware and Nvidia's GPUs. Tesla will spend $3-4 billion on Nvidia hardware and the rest of its $10 billion AI budget internally.

Portfolio Pulse from Anan Ashraf

June 21, 2024 | 12:20 pm

PALI

Palisade Bio has provided an update on its collaboration with Strand Life Sciences, which is advancing Palisade Bio's precision medicine approach. The collaboration has identified candidate PDE4-related biomarkers overlapping with UC pathophysiology and is developing an innovative selection strategy.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2024 | 12:18 pm

TAK

Takeda's HyQvia has been approved as a replacement therapy for primary and secondary humoral immunodeficiency in pediatric patients. This approval allows for home administration, providing a new treatment option for children and adolescents with immunodeficiencies.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2024 | 12:17 pm

LLY

NVO

ZLDPF

Zealand Pharma announced positive Phase 1b trial results for its weight management drug, petrelintide, showing significant weight loss and good tolerability. This news comes as the weight-loss drug market, dominated by Novo Nordisk's Ozempic and WeGovy, is projected to grow significantly.

Portfolio Pulse from Benzinga Neuro

June 21, 2024 | 12:12 pm

APRE

Aprea Therapeutics will host a virtual Key Opinion Leader (KOL) event on June 24, 2024, to discuss APR-1051, a selective oral WEE1 inhibitor. The event will feature medicinal chemistry expert Joseph Vacca and University of Pennsylvania's Eric J. Brown, who will discuss preclinical findings.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2024 | 12:12 pm

APRE

Aprea Therapeutics announced it will host a virtual Key Opinion Leader (KOL) event focused on its drug candidate APR-1051.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2024 | 12:11 pm

RCAT

UMAC

Unusual Machines has announced a partnership with Red Cat to provide the first drone and components for the FANG line of FPV systems. This partnership emphasizes their commitment to onshoring production and FPV technology expertise.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2024 | 12:07 pm

SLE

Super League Gaming (SLE) has issued a mid-year update from CEO Ann Hand, highlighting expectations for record revenues in 2024 and profitability in the second half of the year. The company has over 130 million monthly active users engaged through more than 7,000 experiences.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2024 | 12:06 pm